Rubin JT - Search Results

1

New biologic agents come to bat for cancer therapy.

Lotze MT, Rubin JT, Zeh HJ. Lotze MT, et al. Among authors: rubin jt. Curr Opin Oncol. 1992 Dec;4(6):1116-23. Curr Opin Oncol. 1992. PMID: 1457526 Review.

2

Genetically marking human cells--results of the first clinical gene transfer studies.

Cai Q, Rubin JT, Lotze MT. Cai Q, et al. Among authors: rubin jt. Cancer Gene Ther. 1995 Jun;2(2):125-36. Cancer Gene Ther. 1995. PMID: 7621260 Review.

3

Acute gastric mucosal injury associated with the systemic administration of interleukin-4.

Rubin JT, Lotze MT. Rubin JT, et al. Surgery. 1992 Mar;111(3):274-80. Surgery. 1992. PMID: 1542854 Clinical Trial.

4

Immune function and dysfunction. A primer for the radiologist.

Rubin JT, Lotze MT. Rubin JT, et al. Radiol Clin North Am. 1992 May;30(3):507-23. Radiol Clin North Am. 1992. PMID: 1570393 Review.

5

Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans.

Rubin JT, Elwood LJ, Rosenberg SA, Lotze MT. Rubin JT, et al. Cancer Res. 1989 Dec 15;49(24 Pt 1):7086-92. Cancer Res. 1989. PMID: 2582450

6

Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trial.

Rubin JT, Lotze MT, Rosenfelder D, Brumfield A, Howells R, Schwartz R, Sylvestri S, Sammon J, Bron K, Orens P, et al. Rubin JT, et al. Ann Surg Oncol. 1995 Jul;2(4):351-9. doi: 10.1007/BF02307069. Ann Surg Oncol. 1995. PMID: 7552626 Clinical Trial.

7

HLA-DQ1 is associated with clinical response and survival of patients with melanoma who are treated with interleukin-2.

Rubin JT, Day R, Duquesnoy R, Simonis B, Adams S, Lee J, Lotze MT. Rubin JT, et al. Ther Immunol. 1995 Feb;2(1):1-6. Ther Immunol. 1995. PMID: 7553066

8

The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy.

Lotze MT, Hellerstedt B, Stolinski L, Tueting T, Wilson C, Kinzler D, Vu H, Rubin JT, Storkus W, Tahara H, Elder E, Whiteside T. Lotze MT, et al. Among authors: rubin jt. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S109-14. Cancer J Sci Am. 1997. PMID: 9457405 Clinical Trial.

9

Potent antitumor effects of intra-arterial injection of fibroblasts genetically engineered to express IL-12 in liver metastasis model of rat: no additional benefit of using retroviral producer cell.

Iwazawa T, Chau GY, Mori T, Dookeran KA, Rubin JT, Watkins S, Robbins PD, Lotze MT, Tahara H. Iwazawa T, et al. Among authors: rubin jt. Cancer Gene Ther. 2001 Jan;8(1):17-22. doi: 10.1038/sj.cgt.7700272. Cancer Gene Ther. 2001. PMID: 11219489

10

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

Marincola FM, Venzon D, White D, Rubin JT, Lotze MT, Simonis TB, Balkissoon J, Rosenberg SA, Parkinson DR. Marincola FM, et al. Among authors: rubin jt. Cancer Res. 1992 Dec 1;52(23):6561-6. Cancer Res. 1992. PMID: 1423301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters